HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jana Bieblova Selected Research

BP-1-102

12/2021Design, synthesis, and in vitro evaluation of BP-1-102 analogs with modified hydrophobic fragments for STAT3 inhibition.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jana Bieblova Research Topics

Disease

3Neoplasms (Cancer)
12/2021 - 08/2016
2Prostatic Neoplasms (Prostate Cancer)
01/2017 - 08/2016
1Adenocarcinoma
01/2017
1Residual Neoplasm
01/2017

Drug/Important Bio-Agent (IBA)

2VaccinesIBA
01/2017 - 08/2016
2Docetaxel (Taxotere)FDA Link
01/2017 - 08/2016
1Cytotoxins (Cytolysins)IBA
12/2021
1BP-1-102IBA
12/2021
1Cytostatic AgentsIBA
01/2017
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2017
1Pharmaceutical PreparationsIBA
08/2016
1Interleukin-12 (IL 12)IBA
08/2016
1InterleukinsIBA
08/2016

Therapy/Procedure

1Immunotherapy
08/2016
1Therapeutics
08/2016
1Drug Therapy (Chemotherapy)
08/2016